When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - Vaccinex achieves enrollment target in pepinemab lung cancer study
Pfizer Inc.
Vaccinex (VCNX-1.5%) announces full enrollment (n=62) in a Phase 1b/2 clinical trial, CLASSICAL-Lung, evaluating lead candidate pepinemab (VX15/2503), combined with Pfizer's (PFE+0.6%) Bavencio (avelumab), in patients with advanced non-small cell lung cancer (NSCLC).
More news on: Vaccinex, Inc., Pfizer Inc., Merck KGaA ADR, Healthcare stocks news, Stocks on the move,